81 related articles for article (PubMed ID: 18332314)
21. In vitro corneal pathogenicity of Acanthamoeba.
Larkin DF; Berry M; Easty DL
Eye (Lond); 1991; 5 ( Pt 5)():560-8. PubMed ID: 1794422
[TBL] [Abstract][Full Text] [Related]
22. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis.
Lehmann OJ; Green SM; Morlet N; Kilvington S; Keys MF; Matheson MM; Dart JK; McGill JI; Watt PJ
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1261-5. PubMed ID: 9620088
[TBL] [Abstract][Full Text] [Related]
23. Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba.
Khan NA; Jarroll EL; Panjwani N; Cao Z; Paget TA
J Clin Microbiol; 2000 Aug; 38(8):2858-61. PubMed ID: 10921939
[TBL] [Abstract][Full Text] [Related]
24. Acanthamoebae bind to rabbit corneal epithelium in vitro.
Panjwani N; Zhao Z; Baum J; Hazlett LD; Yang Z
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1858-64. PubMed ID: 9286276
[TBL] [Abstract][Full Text] [Related]
25. Oral immunization with Acanthamoeba castellanii mannose-binding protein ameliorates amoebic keratitis.
Garate M; Alizadeh H; Neelam S; Niederkorn JY; Panjwani N
Infect Immun; 2006 Dec; 74(12):7032-4. PubMed ID: 16982837
[TBL] [Abstract][Full Text] [Related]
26. Binding of Acanthamoeba to [corrected] mannose-glycoproteins of corneal epithelium: effect of injury.
Jaison PL; Cao Z; Panjwani N
Curr Eye Res; 1998 Aug; 17(8):770-6. PubMed ID: 9723990
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic Acanthamoeba induces apoptosis of human corneal epithelial cells.
Zheng X; Uno T; Goto T; Zhang W; Hill JM; Ohashi Y
Jpn J Ophthalmol; 2004; 48(1):23-9. PubMed ID: 14767646
[TBL] [Abstract][Full Text] [Related]
28. Development of a modified gentamicin protection assay to investigate the interaction between Campylobacter jejuni and Acanthamoeba castellanii ATCC 30010.
Dirks BP; Quinlan JJ
Exp Parasitol; 2014 May; 140():39-43. PubMed ID: 24632191
[TBL] [Abstract][Full Text] [Related]
29. Effect of immunization with the mannose-induced Acanthamoeba protein and Acanthamoeba plasminogen activator in mitigating Acanthamoeba keratitis.
Alizadeh H; Neelam S; Niederkorn JY
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5597-604. PubMed ID: 18055809
[TBL] [Abstract][Full Text] [Related]
30. Characterization and pathogenetic role of proteinase from Acanthamoeba castellanii.
Na BK; Kim JC; Song CY
Microb Pathog; 2001 Jan; 30(1):39-48. PubMed ID: 11162184
[TBL] [Abstract][Full Text] [Related]
31. Human IgA inhibits adherence of Acanthamoeba polyphaga to epithelial cells and contact lenses.
Campos-Rodríguez R; Oliver-Aguillón G; Vega-Pérez LM; Jarillo-Luna A; Hernández-Martínez D; Rojas-Hernández S; Rodríguez-Monroy MA; Rivera-Aguilar V; González-Robles A
Can J Microbiol; 2004 Sep; 50(9):711-8. PubMed ID: 15644925
[TBL] [Abstract][Full Text] [Related]
32. Interaction of Pseudomonas aeruginosa with human tear fluid components.
McNamara NA; Andika R; Kwong M; Sack RA; Fleiszig SM
Curr Eye Res; 2005 Jul; 30(7):517-25. PubMed ID: 16020285
[TBL] [Abstract][Full Text] [Related]
33. In vitro inhibition of protease-activated receptors 1, 2 and 4 demonstrates that these receptors are not involved in an Acanthamoeba castellanii keratitis isolate-mediated disruption of the human brain microvascular endothelial cells.
Iqbal J; Naeem K; Siddiqui R; Khan NA
Exp Parasitol; 2014 Nov; 145 Suppl():S78-83. PubMed ID: 24703976
[TBL] [Abstract][Full Text] [Related]
34. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
[TBL] [Abstract][Full Text] [Related]
35. IgA antibodies to Toxoplasma gondii in human tears.
Meek B; Klaren VN; van Haeringen NJ; Kijlstra A; Peek R
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2584-90. PubMed ID: 10937570
[TBL] [Abstract][Full Text] [Related]
36. Effects of multipurpose contact lens care solutions on the adhesiveness of Acanthamoeba to corneal epithelial cells.
Imayasu M; Uno T; Ohashi Y; Cavanagh HD
Eye Contact Lens; 2009 Sep; 35(5):246-50. PubMed ID: 19672197
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
[TBL] [Abstract][Full Text] [Related]
38. Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations.
Brindley N; Matin A; Khan NA
Exp Parasitol; 2009 Mar; 121(3):254-6. PubMed ID: 19071116
[TBL] [Abstract][Full Text] [Related]
39. Cytopathogenicity of Acanthamoeba isolates on rat glial C6 cell line.
Lagmay JP; Matias RR; Natividad FF; Enriquez GL
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):670-7. PubMed ID: 10928358
[TBL] [Abstract][Full Text] [Related]
40. The role of the innate and adaptive immune responses in Acanthamoeba keratitis.
Niederkorn JY
Arch Immunol Ther Exp (Warsz); 2002; 50(1):53-9. PubMed ID: 11916309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
